Evidence map›Paper›PMID 40273066›Full record

ArticlePloS one2025

Enhancement of YTHDF2 plays a protective role in acute IRI models through downregulation of TUG1 expression.

Hong-Fei He, Shuang Hou, Xiao-Ya Ma, Song-Song Huang, Bo Yang, Jun-Kang Wang, Yuan Xu, Lei Tan, Hai-Yang Li

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hong-Fei HeDepartment of hepatobiliary surgery, Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.ORCID 0009-0000-4504-6625
Shuang HouSchool of clinical medicine, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
Xiao-Ya MaCenter for Energy Metabolism and Reproduction, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, People's Republic of China.
Song-Song HuangDepartment of Pathology, Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
Bo YangSchool of clinical medicine, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
Jun-Kang WangSchool of clinical medicine, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
Yuan XuSchool of clinical medicine, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
Lei TanInnovation Center of Suzhou Nanjing Medical University, Suzhou City, Jiangsu Province, People's Republic of China.ORCID 0000-0002-8473-4911
Hai-Yang LiDepartment of hepatobiliary surgery, Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the major causes of acute kidney injury, renal ischemia-reperfusion is a common health problem in a series of clinical situations, including renal transplantation. Although the mechanisms of renal IRI have been widely investigated, effective strategies are still in lacking for its prevention and treatment. In previous study, we found that the down-regulation of taurine upregulated gene 1, a long non-coding RNA (lncRNA TUG1), markedly alleviated renal IRI through mitigating the cell inflammation and apoptosis. At meanwhile, YTHDF2, an RNA methylation reading protein, was identified as a vital player in IRI of distinct organs, however, not reported in kidney. We then conducted the current study on the function of YTHDF2 in renal IRI and its regulatory role to TUG1. Based on renal IRI models in vitro and in vivo, dramatical down-regulation of YTHDF2 was presented. Subsequently, exogenous perturbation of YTHDF2 was conducted and its protective effects on cell apoptosis were demonstrated in acute IRI exogenous. Furthermore, with the same model, it was indicated that YTHDF2 protein negative regulated TUG1 RNA via direction interaction. Since then, YTHDF2 was proved as a potential protector of renal IRI through restraining of TUG1. In further speculation, induction of YTHDF2 in IRI will possibly become a possible strategy to combat the pathological process post renal transplantation or other clinical conditions.

Indexed as

Acute Kidney InjuryReperfusion InjuryRNA-Binding ProteinsRNA, Long NoncodingAnimalsApoptosisDisease Models, AnimalDown-RegulationHumansKidneyMaleMicelong non-coding RNA TUG1, mouseRNA-Binding ProteinsRNA, Long NoncodingYTHDF2 protein, mouse

Identifiers

PMID40273066
PMCPMC12021219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.